Content area

Abstract

10,11-Dihydro-10-hydroxy carbamazepine has been degraded in deionized water and wastewater samples using an electrochemical process. The anode used in the treatment process was graphite-PVC. Different factors such as initial concentration, NaCl amount, type of matrix, applied voltage, role of H2O2, and pH solution were investigated in the treatment of 10,11-dihydro-10-hydroxy carbamazepine. From the outcome of the results, it was noticed that the chemical oxidation of the compound followed a pseudo-first-order reaction. The rate constants were ranged between 22 × 10−4 and 483 × 10−4 min−1. After electrochemical degradation of the compound, several by-products were raised, and they were analyzed using an accurate instrument, liquid chromatography-time of flight-mass spectrometry (LC-TOF/MS). In the present study, the treatment of the compound was followed by high energy consumption under 10 V and 0.5 g NaCl, reaching up to 0.65 Wh mg−1 after 50 min. The inhibition of E. coli bacteria after incubation of the treated 10,11-dihydro-10-hydroxy carbamazepine sample was investigated in terms of toxicity.

Details

Title
Electrochemical degradation of 10,11-dihydro-10-hydroxy carbamazepine as the main metabolite of carbamazepine
Author
Mussa, Zainab Haider 1 ; Al-Qaim, Fouad Fadhil 2 

 College of Pharmacy, University of Al-Ameed, Karbala, Iraq 
 College of Science for Women, University of Babylon, Hilla, Iraq (GRID:grid.427646.5) (ISNI:0000 0004 0417 7786); Malaysia-Japan International Institute of Technology, Universiti Teknologi Malaysia, Kuala Lumpur, Malaysia (GRID:grid.410877.d) (ISNI:0000 0001 2296 1505) 
Pages
50457-50470
Publication year
2023
Publication date
Apr 2023
Publisher
Springer Nature B.V.
ISSN
09441344
e-ISSN
16147499
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2807972614
Copyright
© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.